Gilead Sciences said on Monday its experimental once-daily pill reduced symptoms of a chronic ​bowel illness in more patients than ‌placebo in a mid-stage trial.

Log in or sign up to comment.

No comments yet.

← Back to stories

Create FREE account

or login to continue

Signup with GoogleSignup with GitHubSignup with BlueskySignup with Blacksky
Sign up with email

Already have an account? Log in